Sri Lanka's most profitable private hospitals sit underneath a parent with negative equity. The filings show billions in loans and receivables travelling up the structure — and the place it happens is exactly where no regulator stands in the way.
DamithInvest · InwestOutSource: CSE interim filings, 31 Mar 2026+ FY2024/25 annual reports16 JUN 2026
!
Not investment advice. This is independent commentary describing what publicly filed disclosures show. It contains no recommendation to acquire, hold or dispose of any security, and no price target or valuation opinion. Figures are drawn verbatim from Colombo Stock Exchange filings cited at the end. Readers should form their own conclusions and consult a licensed adviser. Prepared in keeping with SEC Sri Lanka guidance on independent research.
SHL
Softlogic Holdings
NAV/sh −48.99
ASIR
Asiri Hospital Hldgs
NAV/sh +21.57
AMSL
Asiri Surgical
NAV/sh +14.89
SCAP
Softlogic Capital
NAV/sh −1.06
AAIC
Softlogic Life
NAV/sh +44.25
What the disclosures show — in one read
The Asiri hospitals are strong operating businesses: Asiri Hospital Holdings posted Rs 5.17bn profit (FY26) and Asiri Surgical Rs 0.98bn, both with solidly positive equity. This is not an operating-distress story.
The disclosure question is balance-sheet quality and direction of cash. Across the two listed hospitals, roughly Rs 16.9bn of assets sit as loans and receivables to related parties — a portion lent up to a Softlogic group whose holding company reports negative equity of Rs 44.7bn. The hospitals have already impaired part of what the ultimate parent owes, two years running.
The regulated arms — Softlogic Life (IRCSL-licensed) and Softlogic Capital — show only modest, ring-fenced parent exposure. The upstream lending is concentrated in the unregulated hospital companies. The open question for minority holders is recoverability, and whether the trail keeps growing.
01 The structure
Who owns whom — and which way the money moves
Softlogic Holdings sits at the top with two arms beneath it: the healthcare arm (the listed Asiri hospitals) and the financial-services arm (Softlogic Capital, which holds the IRCSL-regulated insurer Softlogic Life and Softlogic Finance). Control runs downward. In the filings, lending runs the other way.
Related-party flow map — loans & receivables travelling up the group
Balances as disclosed at 31 Mar 2026 (interim). Arrows show direction of lending, not ownership.
How to read it. Green boxes are cash-generative, positive-equity hospitals. The red box at the top is the parent the loans flow toward. The purple box is the regulated financial-services arm, where parent exposure is small because the IRCSL and CBSL ring-fence policyholder and depositor funds. Sources: AMSL & ASIR interims (Loans Granted to Related Parties); SHL interim (equity, guarantees); SCAP & AAIC interims (related-party notes).
02 Equity value
Positive hospitals, negative parent
The single starkest fact in the group is the gap between the listed hospitals' book equity and the holding company's. The hospitals carry real, positive net assets. The parent's net assets are deeply negative — its shares trade in the market while its disclosed net liability per share is almost Rs 49.
Net assets per share, as disclosed at 31 Mar 2026 (group)
Rupees per share. Bars below the axis are net liabilities.
*SCAP shows positive total group equity (Rs 6.27bn) only because of Rs 7.31bn of non-controlling interest; the share attributable to the parent's own holders is −Rs 1.04bn (NAV/sh −1.06). Source: each company's 31 Mar 2026 interim statement of financial position.
A company can carry negative equity and still trade — but a market price of around Rs 13 against a disclosed net liability of Rs 48.99 per share is the kind of gap a reader should understand before forming a view, not discover afterwards.
03 How big is it
Counting the related-party book
Here is the honest tally. Not every rupee goes "to Softlogic" — a large part of Asiri Surgical's book is lent to other Asiri hospitals (healthcare-to-healthcare, lower risk). What matters is (a) the total scale relative to each company's equity, and (b) the slice named as going to the wider Softlogic group.
ASIR · RP loans
10.83 bn
Rs · 31 Mar 2026 (NC 7.99 + C 2.84)
AMSL · RP loans
6.08 bn
Rs · 31 Mar 2026 (NC 1.98 + C 4.10)
Combined hospitals
16.91 bn
Rs · combined related-party loans
vs AMSL equity
~77%
RP book as a share of AMSL's equity
Asiri Surgical — who the loans go to (FY2024/25 audited, Note 20)
Counterparty
Relationship
FY25 (Rs)
FY24 (Rs)
Asiri Hospital Holdings
Parent
945,689,367
764,060,230
Central Hospital Ltd
Common control
760,711,926
711,185,826
Asiri Central Hospital Ltd
Common control
625,001,622
581,981,892
Asiri Hospital Matara
Common control
227,072,260
215,899,443
Other related parties (incl. Softlogic group)
Note 20.2
1,178,364,488
1,543,520,954
Total loans granted (current)
3,736,839,663
3,816,648,345
Source: Asiri Surgical Hospital PLC Annual Report 2024/25, Note 20 & Note 20.1. Adding the non-current portion (Rs 1.98bn) reconciles to the Note 15 total of Rs 5.72bn.
The precise point
Most of Asiri Surgical's loan book is intra-Asiri. At Asiri Hospital Holdings, by contrast, the related-party note names Softlogic Holdings PLC itself, plus Softlogic Brands, Supermarket, Retail and Communications — that is where the direct exposure to the distressed parent group is largest, inside the Rs 10.83bn. To quote an exact "to Softlogic Holdings" principal, read ASIR's RPT note in its annual report; the interim names the counterparties but not the per-name split.
04 Write-downs
They are already impairing what the parent owes
This is the tell that turns a structural observation into a recoverability question. Asiri Surgical's own related-party note records impairments taken specifically against the receivable from Softlogic Holdings — Rs 179.9m in FY2024 and a further Rs 65.4m in FY2025. The loans are interest-bearing (Surgical booked Rs 58.9m of interest income from the ultimate parent in FY25), but interest accruing is not the same as principal returning.
Asiri Surgical — disclosed impairments
FY2025 (Rs)
FY2024 (Rs)
Impairment on receivable — Softlogic Holdings (ultimate parent)
65,380,618
179,889,838
Impairment of loans & other receivables (P&L, total)
313,246,762
623,292,653
Provision for bad & doubtful debts
62,066,491
751,195
Source: Asiri Surgical Hospital PLC Annual Report 2024/25 — Related Party note (Ultimate Parent line) & Statement of Cash Flows adjustments (Notes 18.2, 19.5).
Note the trend honestly: the total impairment charge fell from Rs 623m to Rs 313m year-on-year, and the Softlogic-specific charge fell too. The flag is not that write-downs are accelerating — it is that the hospitals are writing down parent-group paper at all, and have done so two years in a row. That is the market telling you something about recoverability.
05 The contrast
Why it happens in the hospitals, not the insurer
If the pattern were simply "the group pulls cash from its subsidiaries," you would expect to see it in the financial-services arm too. You don't — and the reason is regulation.
AAIC Softlogic Life Insurance — ring-fenced
A licensed life insurer under the IRCSL. Its disclosed related-party exposure to the parent and ultimate parent is small: ~Rs 305.8m of investments and Rs 9.1m of interest income. Policyholder funds are protected by regulation, so the insurer cannot freely lend up. NAV/share Rs 44.25; total equity Rs 14.0bn — the healthiest balance sheet in the group.
SCAP Softlogic Capital — thin at the parent line
The financial-services holding layer. Group equity looks positive (Rs 6.27bn) but that is non-controlling interest; equity attributable to its own shareholders is −Rs 1.04bn. It is not a material upstream lender either — its exposures sit largely within the regulated insurance/finance perimeter.
ASIR / AMSL The hospitals — no regulator in the loan path
Hospital companies are not prudentially regulated the way an insurer or a finance company is. There is no capital-adequacy rule or policyholder-fund ring-fence stopping a profitable hospital from lending to its parent. That is precisely why the Rs 16.9bn sits here and not in the insurance arm.
06 Recent event
15 June 2026 — the parent trims its stake
Days before this study, Asiri Hospital Holdings sold a parcel of Asiri Surgical shares into the market. It is a small transaction in isolation — but read alongside the loan trail, it is a second channel of the same thing: value moving up and out of the hospital layer.
Shares sold
19.20 m
= 3.63% of AMSL
Stake after
76.32%
down from 79.96%
Price range
18.50–19.80
Rs · wtd avg ~18.52
Raised
~356 m
Rs · above book (NAV 14.89)
15 Jun 2026
Asiri Hospital Holdings disposes 19.2m AMSL shares across a laddered set of trades (Rs 18.50 – 19.80).
16 Jun 2026
Disclosed to the CSE under Rule 7 / Section 200 as a dealing in which named directors hold a relevant interest — i.e. a related-party / director-interest filing, signed by Softlogic Corporate Services.
After
AMSL public float rises toward ~23.7%. Control unchanged. The disclosure stands alone — it is not a change-of-control transaction.
Reading it fairly
The sale was executed above book value and into a rising tape — orderly, not a distressed dump, and small against the parent's Rs 44.7bn equity hole. So the right frame is not "panic." It is the direction of travel: first loans up, now a slice of the equity stake itself converted to cash. The question a minority holder should sit with is whether this is a one-off top-up or the first tranche of a longer reduction.
07 What this means
The trail, not the trade
Put together, the disclosures describe a coherent picture. Two excellent, profitable hospitals — genuine market leaders — carry a meaningful share of their balance sheets as related-party paper. A portion runs up to a parent group with negative equity, accumulated losses near Rs 93bn, and Rs 38bn of guarantees. The hospitals have begun writing that paper down. The one part of the group that can't participate — the regulated insurer — doesn't.
None of this is hidden. It is in Notes 15, 20 and 32 of the annual reports and in every quarterly related-party disclosure. The gap is that reading it requires separating intra-Asiri lending from upstream-to-parent lending, and most readers never open the note. Closing that gap is the whole point of this study.
What the disclosures show: strong hospital operators, a meaningful related-party book partly directed at a negative-equity parent, impairments taken two years running, and — most recently — a stake trim that moves value the same direction. The reader's own question is recoverability, and whether the trail keeps lengthening.